I just read this e-book, simply because, according to my friend this book is written by some of the ingenious individuals who foresaw and also profited even from the financial collapse. - Sunita
I heard people are using this e-book as a Self-help guide to investing. I recently finished studying it, and never have experimented with any of the strategies; however they all appear to make sense. - Rajiv
A fantastic guide overall. Quite different from almost all other value investing publications because it concentrates on finding unique scenarios that are best to invest in. - Alexis
This particular e-book really opened up my eyes to some fresh opportunities and possibilities that while investing I should be looking for. Once you have read this traditional value investing book you will learn a lot. - Kavita
I really like the writer of this book. It is simple, properly explained, amusing, relevant, and incredibly well planned. This particular e-book is really a holy bible for dealing with unique circumstances in the market. - Saurabh

History of Jupiter Bioscience Ltd.

YEAR EVENTS 1985 - JUPITER ORGA LIMITED was incorporated as a Private Limited Comp. on 21st February, & converted into a Public Limited Comp. vide Resolution passed on 10.3.92 with effect from 1.4.92 as evidenced by Registrar of Companies certificate dated 24.5.94.

- The Comp. is in the Bulk Drugs & Basic Chemicals industry & is currently engaged in the manufacture of Trirnethoprim. Sulfacetamide Sodium & Acetyl PAS.

- The Comp. was initially promoted to take up a small scale project at Bidar, Karnataka, for manufacturing bulk drugs & chemicals. The Comp. has been making cash profits since inception. The Comp. has also taken up trading activities in Sodium PAS Ibuprofen. Sulfamethoxazole, Paracetamol, Ranitidine & Ciprofloxacin.

- The Comp. will have two manufacturing units - one for manufacture of Trimethoprim & Sulfacetamide Sodium at Bidar [Karnatakas], & the other for the manufacture of Sodium Azide, 2-Methyl Resorcinol & 2,6-Dimethoxy Phenol & Trimethoprim at Sangareddy [Andhra Pradeshs].

1995 - The Comp. is setting up a 100% Export Oriented Unit at Cheriyal Village, Sangareddy Mandal, Medak District, Andhra Pradesh for which purpose funds have been raised by way of public issue which opened on 30th January, 1995 & was closed on 2nd February.

- The Comp. has established a Research & Development wing for purpose of developing the speciality chemicals.

1996 - Dr. G.K. Valecha retires at this Annual General Meeting & being eligible for re-appointment, offers himself to be re-elected as Director. Smt. V. Indira retires in the ensuing Annual General Meeting.

1998 - Dr. G.K. Valecha retires by rotation in the ensuing Annual General Meeting & is eligible for reappointment.

1999 - Mr. Gopal K.M. Tangirala retires by rotation in the ensuing Annual General Meeting & is eligible for reappointment. Dr. G.K. Valecha expired during the year & the Board wishes to place on record its appreciation of services rendered by him during his association with the Company.

2000 - Jupiter Organics Ltd., the pharmaceutical & biotechnology company, has floated a wholly-owned subsidiary called Sven Genetech limited for setting up of a separate & focused research & development facility aimed at creating new molecules based on peptide chemistry.

2008

-Hyderabad: Jupiter Biosciences Ltd [JBLs], has forayed into an alliance with GI Logics Inc to develop & market a diagnostic for H. Pylori bacteria, which is responsible for peptic ulcers.